11-02-2021 | Rheumatology | News | Article
Long-term data confirm risk to joints with tanezumab
medwireNews: Long-term treatment with tanezumab is associated with an increased risk for joint-related adverse events in patients with hip or knee osteoarthritis and moderate-to-severe pain despite prior stable use of NSAIDs, phase 3 study data show.
Doctor preparing for patient vaccination/© insta_photos / stock.adobe.com, Vaccination of an adult person in a hospital. Healthcare concept/© Elena / stock.adobe.com